发明名称 |
Use of the modified polysaccharides for heparin neutralization |
摘要 |
The subject of the invention is the use of cationically modified polysaccharides, except for chitosan, for direct neutralization of heparin in blood and physiological fluids in a mammal. Cationic modification of the polysaccharides is achieved using compound containing cationic ammonium groups and/or the polysaccharides are grafted with a polymer containing amine and/or ammonium groups. |
申请公布号 |
US9504707(B2) |
申请公布日期 |
2016.11.29 |
申请号 |
US201113642279 |
申请日期 |
2011.04.20 |
申请人 |
UNIWERSYTET JAGIELLONSKI |
发明人 |
Nowakowska Maria;Szczubiałka Krzysztof;Kamiński Kamil |
分类号 |
A61K31/717;A61K31/721 |
主分类号 |
A61K31/717 |
代理机构 |
Walker & Jocke |
代理人 |
Walker & Jocke |
主权项 |
1. A method of direct neutralization of unfractionated heparin in blood and physiological fluids comprising intravenously administering to a mammal in need thereof cationically modified polysaccharides comprising hydroxypropyl cellulose grafted with N-acrylamidopropyl-N,N,N-trimethylammonium chloride. |
地址 |
Crakow PL |